Balachandran Madhavan sold $526K of QURE
Balachandran Madhavan sold 11,685 shares of uniQure N.V. (QURE) at an average of $45.06 ($42.60–$47.08, $0.53M total) across 3 trades on 2026-06-17 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed open-market sale totals $526,484.60 across three trades on 2026-06-17, with a stated 10b5-1 pre-arranged plan.
Market read
This provides a fresh datapoint on insider activity, but it does not introduce new fundamentals or catalysts for QURE.
What to watch
Traders may over-weight insider sales; without concurrent news (trial results, guidance, financing), the signal is usually weak and should be treated as sentiment noise.
Background
The article is a newly filed SEC Form 4 insider transaction for uniQure N.V. (QURE) by director Balachandran Madhavan.
Ticker impact
uniQure director Balachandran Madhavan sold $526,484 of QURE shares via an open-market sale under a 10b5-1 plan on 2026-06-17.
Likely limited, short-lived sentiment impact; no clear directional fundamental implication from this Form 4 alone.
The filing is a routine Form 4 insider transaction with disclosed trade size, dates, and 10b5-1 pre-arrangement, without any accompanying operational or guidance change.
Market effects
Minimal; this is company-specific insider activity with no sector-wide regulatory/clinical catalyst mentioned.
None indicated; no cross-border deal, listing, or macro linkage described.
None indicated; no global partnership, trial, or financing event disclosed.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect liquidity/tax planning rather than bearish expectations.
Key entities
- issueruniQure N.V.
Subject of the Form 4 insider transaction; director Balachandran Madhavan sold shares.
- insiderBalachandran Madhavan
Director who executed the open-market sale under a 10b5-1 plan.
